| Dear Subscriber, |
| Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories. To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y . |
| Aid / Disasters News | |
| Haiti: An Alarming Resurgence Of Cholera The cholera epidemic in Haiti is far from over, with a sharp increase in cases seen in the capital, Port-au-Prince, and outbreaks reported elsewhere in the country, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) said today. | 03 June 2011 |
| Expedition To Measure Radioactive Contaminants In Pacific The Woods Hole Oceanographic Institution (WHOI) will lead the first international, multidisciplinary assessment of the levels and dispersion of radioactive substances in the Pacific Ocean off the Fukushima nuclear power plant - a research effort funded by the Gordon and Betty Moore Foundation. | 03 June 2011 |
| Red Cross Helping After Tornadoes Tear Through Massachusetts The American Red Cross is responding in Massachusetts where tornadoes cut a destructive swath through the western part of the state yesterday. At least 480 people spent Wednesday night in Red Cross shelters in Massachusetts. | 03 June 2011 |
| National Disaster Medical System Teams Return From Missouri Tornado Response U.S. Department of Health and Human Services (HHS) personnel from the National Disaster Medical System (NDMS) began returning to their home states today after deploying to assist in mass fatality operations in the aftermath of a devastating tornado in Joplin, Mo. | 03 June 2011 |
| Alcohol / Addiction / Illegal Drugs News | |
| Study Of Gambling Behaviour May Improve Understanding Of Risky Choices And Gambling Addictions Psychology researchers at the University of Alberta have found an interesting wrinkle in the decision- making process people use when gambling: People confronted with risky choices respond differently when they rely on past experiences, rather than when they just focus on the odds of winning or losing. | 03 June 2011 |
| Alzheimer's / Dementia News | |
| Discovery Of Drug Candidate For Alzheimer's, Huntington's Disease Scientists at the Gladstone Institutes have identified a drug candidate that diminishes the effects of both Alzheimer's disease and Huntington's disease in animal models, offering new hope for patients who currently lack any medications to halt the progression of these two debilitating illnesses. | 03 June 2011 |
| Huntington's Disease Breakthrough Announced By Trans-Atlantic Team Medical researchers may have uncovered a novel approach to treat an incurable and ultimately fatal neurodegenerative disease that affects hundreds of thousands of people.Two international studies, one led by the University of Leicester, and the other a collaboration with Leicester led by scientists in the USA, hold out promise for slowing down the development of Huntington's disease - and potentially, Alzheimer's and Parkinson's diseases. | 03 June 2011 |
| Anxiety / Stress News | |
| Exercise Should Be Considered For PTSD Therapy Doctors are increasingly prescribing exercise as medicine for their patients to prevent and treat disease and injury. A growing collection of evidence also suggests that exercise can be therapeutic for individuals suffering from Posttraumatic Stress Disorder (PTSD), including victims of rape. | 03 June 2011 |
| Mylan Receives Approval For Generic Version Of Effexor XR® Capsules Mylan Inc. (Nasdaq: MYL) announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Venlafaxine Hydrochloride (HCl) Extended-release (ER) Capsules, 37. | 03 June 2011 |
| Arthritis / Rheumatology News | |
| Promising New Approach To Autoimmune Diseases Researchers from Harvard Medical School and MIT have developed a new approach for identifying the "self" proteins targeted in autoimmune diseases such as multiple sclerosis, diabetes and rheumatoid arthritis. | 03 June 2011 |
| Autism News | |
| Toddlers At Risk For Autism Identified By Autism Experts/Pediatricians Partnership Parents and health care providers can't always tell whether toddlers display signs of autism syndrome disorder (ASD), but new research from the University of Utah shows that a significant portion of at-risk children between 14-24 months can be identified through systematic screening by autism experts and providers working together. | 03 June 2011 |
| Research Reveals Effectiveness Of Seizure Treatments For Children With Autism Physicians will have a better guide for more effectively managing treatment of children experiencing seizures related to autism with the results of a study by researchers at Arizona State University and the University of Texas-Houston. | 03 June 2011 |
| The Adult Brain Requires MeCP2 For Proper Functioning A paper published online in Science provides evidence that the Methyl-CpG-Binding Protein 2 (MeCP2) is required throughout life to maintain healthy brain function. The findings are reported from the Baylor College of Medicine lab of Huda Zoghbi, HHMI investigator and Director of the Jan and Dan Duncan Neurological Research Institute. | 03 June 2011 |
| Therapies To Improve Biochemical Functions Hold Promise As Treatments For Autism Two promising new treatments to aid people with autism have shown effectiveness in pilot studies conducted by an Arizona State University professor and private researchers. Several studies indicate that children with autism often have abnormalities in critical biochemical functions that help maintain health - specifically methylation, glutathione, and mitochondrial functions. | 03 June 2011 |
| Renowned Autism Expert Dr. Catherine Lord To Lead New Comprehensive Autism Treatment Institute A leading autism authority who is helping transform the way autism spectrum disorders are diagnosed and treated, Dr. Catherine Lord has been named director of the new Institute for Brain Development at NewYork-Presbyterian Hospital, Weill Cornell Medical College and Columbia University Medical Center. | 03 June 2011 |
| Biology / Biochemistry News | |
| The Glass Is Half Empty For Stressed Bees When people are depressed or anxious, they are much more likely to see their glass as half empty than half full. In tough times, evidence of that same pessimistic outlook can be seen in dogs, rats, and birds. | 03 June 2011 |
| Microscopic Worms Could Help Open Up Travel Into Deep Space A space flight by millions of microscopic worms could help us overcome the numerous threats posed to human health by space travel. The Caenorhabditis elegans (C. elegans) have also given experts an insight into how to block muscle degradation in the sick and elderly. | 03 June 2011 |
| FSU Scientist Leads Research On AIDS-Related Cancer In the early days of the AIDS epidemic, a once-rare form of cancer known as Kaposi's sarcoma (KS) emerged as a frequent harbinger of HIV. Its stigma was best illustrated by Tom Hanks, who portrayed a gay man trying to conceal the cancerous skin lesions from his co-workers in the 1993 movie "Philadelphia. | 03 June 2011 |
| Bird Flu / Avian Flu News | |
| Busted! Vira 38 Importer Arrested For Illegal Bird Flu "Prevention" In 2005 the bird or avian flu was no joke. Charles Hensley, however, has been arrested for pushing medications in 2005 and marketing the illegal drug Vira 38, not approved by the FDA or in Hong Kong for that matter, which was supposedly able to prevent symptoms of the deadly outbreak that gripped the globe. | 03 June 2011 |
| Blood / Hematology News | |
| Celgene And Acceleron Initiate Phase 2/3 Study Of ACE-011 (Sotatercept) To Treat Chemotherapy-Induced Anemia In Patients With Lung Cancer Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases, and Celgene Corporation (NASDAQ: CELG) today announced the initiation of the first part of a Phase 2/3 clinical study of ACE-011 (sotatercept) for the treatment of chemotherapy-induced anemia (CIA) in patients with metastatic non-small cell lung cancer (NSCLC). | 03 June 2011 |
| Use Of Clot Busters For Stroke Increased From 2005 To 2009, But Still Low The use of clot-busting drugs to treat acute ischemic stroke increased from 2005 through 2009 - but is still low, according to research reported in Stroke: Journal of the American Heart Association. | 03 June 2011 |
| Bones / Orthopedics News | |
| Role Of Gene Regulator In Skeletal Muscles Demonstrated Fast muscles, such as the thigh muscle in a sprinter, deliver energy quickly but fatigue quickly. Slow muscles, such as the soleus muscle in the lower calf, are less forceful but important for posture and endurance. | 03 June 2011 |
| Hip Strengthening Exercises Improved Running Mechanics, Lessened Knee Pain Hip strengthening exercises performed by female runners not only significantly reduced patellofemoral pain - a common knee pain experienced by runners - but they also improved the runners' gaits, according to Indiana University motion analysis expert Tracy Dierks. | 03 June 2011 |
| Two Minutes Of Exercise A Day Can Keep The Pain Away As little as two minutes of exercise a day can reduce pain and tenderness in adults with neck and shoulder problems, according to research being presented today at the 58th Annual Meeting of the American College of Sports Medicine and 2nd World Congress on Exercise is Medicine®. | 03 June 2011 |
| Microscopic Worms Could Help Open Up Travel Into Deep Space A space flight by millions of microscopic worms could help us overcome the numerous threats posed to human health by space travel. The Caenorhabditis elegans (C. elegans) have also given experts an insight into how to block muscle degradation in the sick and elderly. | 03 June 2011 |
| Stem Cells May Prevent Need For Joint Replacements, If FDA Allows It Patients' own adult stem cells show great potential in regenerative medicine, including orthopedic applications. Stem cells isolated from bone marrow can enable bone and cartilage to heal.Once removed, the patients' cells are processed and allowed to multiply in tissue culture. | 03 June 2011 |
| Breast Cancer News | |
| Emerging Trends In Radiation Therapy For Women Over 70 With Early Stage Breast Cancer Patterns of radiation usage in breast conserving therapy for women 70 years and older with stage I breast cancer are changing: more women are opting for radioactive implants and those with estrogen positive tumors are opting out of radiation therapy, according to an abstract being presented at the American Society of Clinical Oncology annual meeting in Chicago by Thomas Jefferson University Hospital researchers on Saturday, June 4. | 03 June 2011 |
| Stopping Heart Disease In Cancer Patients Before It Starts Researchers in the Faculty of Medicine & Dentistry are trying to reverse a devastating trend: cancer survivors developing cardiovascular disease, one of the top two killers in Canada.Ian Paterson, an assistant professor of cardiology at the University of Alberta and Edie Pituskin, a registered nurse and PhD candidate in the Faculty of Rehabilitation Medicine, are starting what is called the MANTICORE clinical trials. | 03 June 2011 |
| Silencing Deadly Cellular Cross Talk In Breast Cancer While it is already known that breast cancer cells create the conditions for their own survival by communicating their needs to the healthy cells that surround them, Australian researchers have identified a new way of turning off that cellular cross talk. | 03 June 2011 |
| FDA: Breast Thermography Not A Substitute For Mammography The U.S. Food and Drug Administration today warned women not to substitute breast thermography for mammography to screen for breast cancer.Unlike mammography, in which an X-ray of the breast is taken, thermography produces an infrared image that shows the patterns of heat and blood flow on or near the surface of the body. | 03 June 2011 |
| The World Leader In Molecular Breast Imaging To Premiere Largest Detector In The Industry Dilon Diagnostics will introduce the latest advancement in molecular breast imaging (MBI) this week at the Society of Nuclear Medicine (SNM) Meeting in San Antonio, Texas, with the premiere of its FDA-cleared Dilon 6800® Acella Gamma Camera system. | 03 June 2011 |
| National Clinical Trial To Test Novel Approach To Treat Triple-Negative Breast Cancer A multicenter clinical trial led by a researcher at the University of Maryland Marlene and Stewart Greenebaum Cancer Center will evaluate a new approach to treat triple-negative breast cancer, an often-aggressive type of cancer that is more common among African-Americans and young women. | 03 June 2011 |
| Cancer / Oncology News | |
| Targeting Cancer Treatment - Specific Factors Of A Patient's Tumor Cancer treatment is depending more and more today on specific factors of a patient's tumor, including gene mutations, or proteins that are commonly typical of certain cancer cells, rather than focusing on where in the body the cancer started. | 03 June 2011 |
| Canada's Two Largest Cancer Fundraisers Team Up To Conquer Cancer A landmark partnership announced today between Canada's two largest cancer charities, The Princess Margaret Hospital Foundation and the Canadian Cancer Society, will raise significant amounts of money towards conquering cancer through the national expansion of Road Hockey to Conquer Cancer. | 03 June 2011 |
| Study Confirms Long-Lasting Anticancer Benefit Of Zoledronic Acid For Women With Early-Stage Breast Cancer Women with early-stage hormone receptor-sensitive breast cancer* given zoledronic acid, a bone strengthening drug, in addition to standard hormone therapy for 3 years following surgery are at significantly (32%) less risk of their cancer returning, and the effect is long lasting, according to the long-term results of the landmark Austrian Breast and Colorectal Cancer Study Group trial-12 (ABCSG-12) published Online First in The Lancet Oncology. | 03 June 2011 |
| Study Shows Advanced Colorectal Cancer Patients Do Not Benefit From Adding Cetuximab To Standard Chemotherapy But Could Benefit From Treatment Breaks The targeted therapy cetuximab does not improve progression-free survival (PFS) or overall survival (OS) when added to standard chemotherapy as a first-line treatment for advanced colorectal cancer, according to the largest trial to date in advanced bowel cancer. | 03 June 2011 |
| Health Benefit Of Green Tea: Mechanism Discovered, New Approach To Autoimmune Disease One of the beneficial compounds found in green tea has a powerful ability to increase the number of "regulatory T cells" that play a key role in immune function and suppression of autoimmune disease, according to new research in the Linus Pauling Institute at Oregon State University. | 03 June 2011 |
| Wealthier Patients Living Longer Than Poorer Patients With Glioblastoma Survival rates of wealthier patients and those younger than 70 with glioblastoma, the most common and aggressive malignant brain tumor, have improved since 2000, whereas rates for those living in poorer areas and older than 70 have remained stagnant, according to an abstract being presented at the American Society of Clinical Oncology annual meeting in Chicago by Thomas Jefferson University Hospital researchers on Saturday, June 4. | 03 June 2011 |
| Physicians Discover How Cancer Drug Works To Help Prevent Recurrent Kidney Disease A collaboration of Miller School physicians, surgeons and scientists has unlocked the mechanism of a drug used to prevent recurrent kidney disease. The finding, which has implications for the diagnosis and treatment of many other diseases, involves the action of rituximab, a B-cell lymphoma therapy, in treating recurrent focal segmental glomerulosclerosis (FSGS) in children and young adults. | 03 June 2011 |
| Stopping Heart Disease In Cancer Patients Before It Starts Researchers in the Faculty of Medicine & Dentistry are trying to reverse a devastating trend: cancer survivors developing cardiovascular disease, one of the top two killers in Canada.Ian Paterson, an assistant professor of cardiology at the University of Alberta and Edie Pituskin, a registered nurse and PhD candidate in the Faculty of Rehabilitation Medicine, are starting what is called the MANTICORE clinical trials. | 03 June 2011 |
| Personalised First-Line Therapy Stalls Lung Cancer For Nearly Twice As Long As Chemotherapy Roche today announced results from the first Phase III study with erlotinib (Tarceva®) in Western patients with a genetically mutated type of advanced non-small cell lung cancer (NSCLC). Results showed that first-line treatment with erlotinib nearly doubled the time people with advanced NSCLC with a specific genetic mutation lived without their disease getting worse compared with chemotherapy (median progression-free survival or PFS: 9. | 03 June 2011 |
| FDA: Treatment With Angiotensin Receptor Blockers For High Blood Pressure Does Not Increase Risk Of Cancer The U.S. Food and Drug Administration today announced that a group of medications used to control high blood pressure, called angiotensin receptor blockers (ARBs), do not increase the risk of developing cancer in patients using the medications. | 03 June 2011 |
| Taking Advantage Of The High Iron Requirements Of Brain Cancer Cells To Improve Treatment Brain cancer therapy may be more effective if the expression of an iron-storing protein is decreased to enhance the action of therapeutic drugs on brain cancer cells, according to Penn State College of Medicine researchers. | 03 June 2011 |
| FSU Scientist Leads Research On AIDS-Related Cancer In the early days of the AIDS epidemic, a once-rare form of cancer known as Kaposi's sarcoma (KS) emerged as a frequent harbinger of HIV. Its stigma was best illustrated by Tom Hanks, who portrayed a gay man trying to conceal the cancerous skin lesions from his co-workers in the 1993 movie "Philadelphia. | 03 June 2011 |
| Cardiovascular / Cardiology News | |
| The Role Of Vitamin D In African-Americans With High Blood Pressure To Be Studied By Wayne State A Wayne State University School of Medicine physician researcher has received a $1.9 million National Institutes of Health grant to study the role of vitamin D in halting and reducing subclinical cardiac damage in African-Americans suffering from high blood pressure. | 03 June 2011 |
| Scientists Discover Gene Regulator That Helps Hearts Through Exercise Providing a medical explanation for why exercise is good for the heart, a team of scientists from Brazil pursuing a study that started in Dr. Ian Phillips' lab at Keck Graduate Institute (KGI) has discovered a new gene regulator called MicroRNA 29 that keeps hearts healthy even under intense exercise. | 03 June 2011 |
| No Cancer Risk With Angiotensin Receptor Blockers Angiotensin receptor blockers (ARBs) do not increase cancer risk, the FDA reported, after investigating the blood pressure medications following a study last year suggesting there might be a small risk. | 03 June 2011 |
| Cholesterol News | |
| Spherix Drug Candidate SPX-106 Shows Statistically Significant Reductions In Serum Triglycerides In Preclinical Testing Spherix Incorporated (NASDAQ: SPEXD) -- an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies -- today announced that its drug candidate, SPX-106, achieved statistically significant reductions in triglycerides and cholesterol when administered in combination with D-tagatose for nine weeks to genetically engineered mice prone to dyslipidemia. | 03 June 2011 |
| Clinical Trials / Drug Trials News | |
| Plexxikon Announces Combination Trials For Vemurafenib In Melanoma Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced new clinical trials in metastatic melanoma testing vemurafenib (PLX4032/RG7204) in combination with other state-of-the-art treatments, including an immunologic therapy and an investigational MEK inhibitor. | 03 June 2011 |
| Seaside Therapeutics Initiates Pivotal Phase 3 Study Of STX209 In Fragile X Syndrome Seaside Therapeutics, Inc. announced today the initiation of a randomized, double-blind, placebo-controlled Phase 3 study to evaluate the effects of STX209 (arbaclofen) on social impairment in adolescents and adults (ages 12 to 25) with fragile X syndrome. | 03 June 2011 |
| Celgene And Acceleron Initiate Phase 2/3 Study Of ACE-011 (Sotatercept) To Treat Chemotherapy-Induced Anemia In Patients With Lung Cancer Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases, and Celgene Corporation (NASDAQ: CELG) today announced the initiation of the first part of a Phase 2/3 clinical study of ACE-011 (sotatercept) for the treatment of chemotherapy-induced anemia (CIA) in patients with metastatic non-small cell lung cancer (NSCLC). | 03 June 2011 |
| New Therapy For Blood Cancers Develolped Clinical researchers at VCU Massey Cancer Center have successfully completed a Phase I clinical trial evaluating a combination of the drugs Bortezomib and Alvocidib in patients with relapsed or refractory blood cancers, paving the way for a Phase II clinical trial to test the safety and effectiveness of the new therapy. | 03 June 2011 |
| Silencing Deadly Cellular Cross Talk In Breast Cancer While it is already known that breast cancer cells create the conditions for their own survival by communicating their needs to the healthy cells that surround them, Australian researchers have identified a new way of turning off that cellular cross talk. | 03 June 2011 |
| NuPathe To Present Additional Migraine Patch Data From Three Trials At AHS NuPathe Inc. (NASDAQ: PATH), a specialty pharmaceutical company focused on the development and commercialization of branded therapeutics for diseases of the central nervous system including neurological and psychiatric disorders, today announced that additional data from a 12-month open-label trial of its transdermal migraine patch (also referred to as Zelrix and NP101) and two other Zelrix trials will be presented at the 53rd Annual Scientific Meeting of the American Headache Society (AHS) this week in Washington, DC. | 03 June 2011 |
| Morphotek®, Inc. Announces Initiation Of MORAb-004 Phase II Study In Melanoma Morphotek®, Inc., a subsidiary of Eisai Inc., announced that it has commenced a multi-center, phase II study of MORAb-004 for the treatment of metastatic melanoma. The study will evaluate MORAb-004, a potentially first-in-class monoclonal antibody that specifically binds to endosialin/tumor endothelial marker-1 (TEM-1), as a single agent therapy comparing its safety and therapeutic activity at two dosages. | 03 June 2011 |
| Spherix Drug Candidate SPX-106 Shows Statistically Significant Reductions In Serum Triglycerides In Preclinical Testing Spherix Incorporated (NASDAQ: SPEXD) -- an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies -- today announced that its drug candidate, SPX-106, achieved statistically significant reductions in triglycerides and cholesterol when administered in combination with D-tagatose for nine weeks to genetically engineered mice prone to dyslipidemia. | 03 June 2011 |
| Case Western Reserve And Edheads Advance Science Education By Using Clinical Trials, Launch Online Education Tools About Stem Cells The National Center for Regenerative Medicine (NCRM) at Case Western Reserve University School of Medicine is teaming up with Edheads, a provider of online education tools, to launch web-based education modules about stem cells. | 03 June 2011 |
| National Clinical Trial To Test Novel Approach To Treat Triple-Negative Breast Cancer A multicenter clinical trial led by a researcher at the University of Maryland Marlene and Stewart Greenebaum Cancer Center will evaluate a new approach to treat triple-negative breast cancer, an often-aggressive type of cancer that is more common among African-Americans and young women. | 03 June 2011 |
| Colorectal Cancer News | |
| Study Shows Advanced Colorectal Cancer Patients Do Not Benefit From Adding Cetuximab To Standard Chemotherapy But Could Benefit From Treatment Breaks The targeted therapy cetuximab does not improve progression-free survival (PFS) or overall survival (OS) when added to standard chemotherapy as a first-line treatment for advanced colorectal cancer, according to the largest trial to date in advanced bowel cancer. | 03 June 2011 |
| Complementary Medicine / Alternative Medicine News | |
| Workers' Compensation Update: Chiropractic Care More Valuable And Cost-Efficient For Low Back Pain Vs. Physician Care, Physical Therapy A recent study conducted by medical and healthcare professionals outside the chiropractic profession, "Health Maintenance Care in Work-Related Low Back Pain and Its Association with Disability Recurrence," (Journal of Occupational and Environmental Medicine, April 2011, Vol. | 03 June 2011 |
| Compliance News | |
| Discovery Of Bitter Blocker Increases Understanding Of Taste, Opening Doors To Better Nutrition And Therapeutic Compliance Although bitterness can sometimes be desirable - such as in the taste of coffee or chocolate - more often bitter taste causes rejection that can interfere with food selection, nutrition and therapeutic compliance. | 03 June 2011 |
| Conferences News | |
| Experimental Vaccine Made From Frozen Immune Cells Shows Promise For Prostate Cancer Patients Metastatic prostate cancer patients who received an investigational vaccine made from their own frozen immune cells lived 10 months longer than those not treated with it, according to data being presented by researchers from the Kimmel Cancer Center at Jefferson at the 2011 American Society of Clinical Oncology annual meeting in Chicago on Saturday, June 4. | 03 June 2011 |
| Wealthier Patients Living Longer Than Poorer Patients With Glioblastoma Survival rates of wealthier patients and those younger than 70 with glioblastoma, the most common and aggressive malignant brain tumor, have improved since 2000, whereas rates for those living in poorer areas and older than 70 have remained stagnant, according to an abstract being presented at the American Society of Clinical Oncology annual meeting in Chicago by Thomas Jefferson University Hospital researchers on Saturday, June 4. | 03 June 2011 |
| Emerging Trends In Radiation Therapy For Women Over 70 With Early Stage Breast Cancer Patterns of radiation usage in breast conserving therapy for women 70 years and older with stage I breast cancer are changing: more women are opting for radioactive implants and those with estrogen positive tumors are opting out of radiation therapy, according to an abstract being presented at the American Society of Clinical Oncology annual meeting in Chicago by Thomas Jefferson University Hospital researchers on Saturday, June 4. | 03 June 2011 |
| Hepatitis C Outcomes Improved Using Videoconferencing Widely-available technology, expert training and real-time feedback helped ensure that patients treated for Hepatitis C in local communities did as well as patients treated at a university-based medical center, results of a new study funded by HHS' Agency for Healthcare Research and Quality show. | 03 June 2011 |
| Depression News | |
| Depression And Negative Thoughts We all have our ups and downs-a fight with a friend, a divorce, the loss of a parent. But most of us get over it. Only some go on to develop major depression. Now, a new study, which will be published in an upcoming issue of Psychological Science, a journal of the Association for Psychological Science, suggests part of the reason may be that people with depression get stuck on bad thoughts because they're unable to turn their attention away. | 03 June 2011 |
| Children And Depression From a distance, Callie (not her real name) appears to be a normal if quiet 5-year-old girl. But when faced with a toy that blows large soap bubbles - an activity that makes the vast majority of kindergarteners squeal and leap with delight - she is uninterested in popping the bubbles or taking a turn with the gun herself. | 03 June 2011 |
| Mylan Receives Approval For Generic Version Of Effexor XR® Capsules Mylan Inc. (Nasdaq: MYL) announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Venlafaxine Hydrochloride (HCl) Extended-release (ER) Capsules, 37. | 03 June 2011 |
| Diabetes News | |
| Promising New Approach To Autoimmune Diseases Researchers from Harvard Medical School and MIT have developed a new approach for identifying the "self" proteins targeted in autoimmune diseases such as multiple sclerosis, diabetes and rheumatoid arthritis. | 03 June 2011 |
| Animas(R) Vibe™, The First Integrated Offering From Animas Corporation And Dexcom, Inc., Receives European CE Mark Approval Animas Corporation announced today the receipt of CE Mark approval for Animas® Vibe™, the first and only continuous glucose monitoring (CGM)-enabled insulin pump system with Dexcom G4™ CGM technology. | 03 June 2011 |
| Eye Health / Blindness News | |
| Improved Understanding Of Lens Transparency, Identification Of Mutations That Cause Congenital Cataracts New research identifies genetic mutations that cause an inherited form of cataracts in humans. The study, published online June 2 by Cell Press in the American Journal of Genetics, provides new insight into the understanding of lens transparency and the development of cataracts in humans. | 03 June 2011 |
| Flu / Cold / SARS News | |
| Fraunhofer USA CMB Announces Positive Phase 1 Interim Results For Its Plant-Produced H1N1 Influenza Vaccine Fraunhofer USA Center for Molecular Biotechnology (CMB), a not-for-profit, Delaware-based organization focused on developing a proprietary plant-based protein production platform and its applications in vaccine and therapeutic fields, today announced positive interim results from the first human trial of plant-produced H1N1 influenza vaccine (HAC1) that began on September 13, 2010. | 03 June 2011 |
| IBio Announces Positive H1N1 Influenza Vaccine Clinical Trial Results iBio, Inc. (NYSE AMEX: IBIO) today announced positive interim results from a Phase 1 clinical trial of an iBioLaunch™ platform-produced subunit vaccine directed against Influenza A/California/04/09 (H1N1). | 03 June 2011 |
| GastroIntestinal / Gastroenterology News | |
| Features Of Bacteria That Caused Epidemic E. Coli In Europe Revealed By Genomics Analysis An outbreak of E. coli infection was detected in Germany about two weeks ago. Health authorities say that over 1500 people have become infected and 17 have died so far. Cases of E. coli infection have been reported in several other European countries, including the UK, the Netherlands, Sweden, Denmark, France, Norway, Spain and Switzerland. | 03 June 2011 |
| Tips And Resources On Foodborne Illness As European Outbreak Of E. Coli Points To Importance Of Safe Food Handling For consumers in the United States concerned by the outbreak of E. coli in Europe, the American College of Gastroenterology offers background on foodborne illness, tips for food safety, and expert insight from its resources on digestive health on what to do in the case of foodborne illness. | 03 June 2011 |
| E. Coli Outbreak, Spain And Germany Seek European Level Aid For Spanish Farmers Spanish vegetable exporters mistakenly got the blame for the E. coli outbreak that has caused over 1,064 cases of bloody diarrhea and 470 cases of HUS (hemolytic-uremic syndrome) in Germany and some other European countries. | 03 June 2011 |
| Research Suggests That Eating Dirt Can Be Good For The Belly Most of us never considered eating the mud pies we made as kids, but for many people all over the world, dining on dirt is nothing out of the ordinary. Now an extensive meta-analysis forthcoming in the June issue of The Quarterly Review of Biology helps explain why. | 03 June 2011 |
| Genetics News | |
| Features Of Bacteria That Caused Epidemic E. Coli In Europe Revealed By Genomics Analysis An outbreak of E. coli infection was detected in Germany about two weeks ago. Health authorities say that over 1500 people have become infected and 17 have died so far. Cases of E. coli infection have been reported in several other European countries, including the UK, the Netherlands, Sweden, Denmark, France, Norway, Spain and Switzerland. | 03 June 2011 |
| Role Of Gene Regulator In Skeletal Muscles Demonstrated Fast muscles, such as the thigh muscle in a sprinter, deliver energy quickly but fatigue quickly. Slow muscles, such as the soleus muscle in the lower calf, are less forceful but important for posture and endurance. | 03 June 2011 |
| Advances In Novel Protein Kinase Inhibitor Development Biotech scientists are working on novel protein kinase inhibitors that are targeting a host of conditions ranging from atherosclerosis to neurodegenerative diseases, reports Genetic Engineering & Biotechnology News (GEN). | 03 June 2011 |
| New Therapy For Blood Cancers Develolped Clinical researchers at VCU Massey Cancer Center have successfully completed a Phase I clinical trial evaluating a combination of the drugs Bortezomib and Alvocidib in patients with relapsed or refractory blood cancers, paving the way for a Phase II clinical trial to test the safety and effectiveness of the new therapy. | 03 June 2011 |
| New Adult Model Of Rett Syndrome An IRSF funded study published in the journal Science has shown that the childhood disorder Rett syndrome, can be reestablished in adult animals by "switching off" a critical disease causing gene in healthy adult animals. | 03 June 2011 |
| Hospitalized Patients With New Type Of MRSA, Probably Of Animal Origin A distinctly new type of methicillin resistant Staphylococcus aureus (MRSA) that is not detected by traditional genetic screening methods has been discovered in patients in Irish hospitals according to research to be published in the journal Antimicrobial Agents and Chemotherapy. | 03 June 2011 |
| Improved Understanding Of Lens Transparency, Identification Of Mutations That Cause Congenital Cataracts New research identifies genetic mutations that cause an inherited form of cataracts in humans. The study, published online June 2 by Cell Press in the American Journal of Genetics, provides new insight into the understanding of lens transparency and the development of cataracts in humans. | 03 June 2011 |
| Non-Independent Mutations Present New Path To Evolutionary Success Mutations of DNA that lead to one base being replaced by another, don't have to happen as single, independent events in humans and other eukaryotes, a group of Indiana University Bloomington biologists has learned after surveying several creatures' genomes. | 03 June 2011 |
| Silencing Deadly Cellular Cross Talk In Breast Cancer While it is already known that breast cancer cells create the conditions for their own survival by communicating their needs to the healthy cells that surround them, Australian researchers have identified a new way of turning off that cellular cross talk. | 03 June 2011 |
| Genome Sequence Identifies Super-Toxic Bacteria As Cause Of The Current European Epidemic The recent outbreak of an E. coli infection in Germany has resulted in serious concerns about the potential appearance of a new deadly strain of bacteria. In response to this situation, and immediately after the reports of deaths, the University Medical Centre Hamburg-Eppendorf and BGI-Shenzhen began working together to sequence the bacterium and assess its human health risk. | 03 June 2011 |
| Microscopic Worms Could Help Open Up Travel Into Deep Space A space flight by millions of microscopic worms could help us overcome the numerous threats posed to human health by space travel. The Caenorhabditis elegans (C. elegans) have also given experts an insight into how to block muscle degradation in the sick and elderly. | 03 June 2011 |
| Taking Advantage Of The High Iron Requirements Of Brain Cancer Cells To Improve Treatment Brain cancer therapy may be more effective if the expression of an iron-storing protein is decreased to enhance the action of therapeutic drugs on brain cancer cells, according to Penn State College of Medicine researchers. | 03 June 2011 |
| Better Understanding Of Environmental 'Fitness' Provided By Evolutionary Biologist Which May One Day Help With Chronic Diseases Working to better predict general patterns of evolution, a University of Houston (UH) biologist and his team have discovered some surprising things about gene mutations that might one day make it possible to predict the progression of chronic disease. | 03 June 2011 |
| Rett Protein Needed For Adult Neuron Function The protein MeCP2 is porridge to the finicky neuron. Like Goldilocks, the neuron or brain cell needs the protein in just the right amount. Girls born with dysfunctional MeCP2 (methyl-CpG-binding protein 2) develop Rett syndrome, a neurological disorder. | 03 June 2011 |
| DNA Sequencing Data Reveals New Hybrid E. Coli Strain Is Cause Of German Outbreak Life Technologies Corporation announced that preliminary data from DNA sequencing performed in cooperation with the University Hospital Muenster, Germany, on the Ion Personal Genome Machine (PGM™) strongly suggests that the bacterium at the root of the deadly outbreak in Germany is a new hybrid type of pathogenic E. | 03 June 2011 |
| Scientists Discover Gene Regulator That Helps Hearts Through Exercise Providing a medical explanation for why exercise is good for the heart, a team of scientists from Brazil pursuing a study that started in Dr. Ian Phillips' lab at Keck Graduate Institute (KGI) has discovered a new gene regulator called MicroRNA 29 that keeps hearts healthy even under intense exercise. | 03 June 2011 |
| Headache / Migraine News | |
| New Data Underscore Nausea Is Significantly Debilitating Symptom Of Migraine, Potentially Impacting Millions Of Patients, Particularly Women A new analysis of the National Headache Foundation's landmark American Migraine Prevalence and Prevention (AMPP) Study, the largest study of migraine and headache sufferers ever conducted, indicates that those with frequent migrainerelated nausea experienced more severe pain and worse outcomes than those with rare or no presence of nausea. | 03 June 2011 |
| NuPathe To Present Additional Migraine Patch Data From Three Trials At AHS NuPathe Inc. (NASDAQ: PATH), a specialty pharmaceutical company focused on the development and commercialization of branded therapeutics for diseases of the central nervous system including neurological and psychiatric disorders, today announced that additional data from a 12-month open-label trial of its transdermal migraine patch (also referred to as Zelrix and NP101) and two other Zelrix trials will be presented at the 53rd Annual Scientific Meeting of the American Headache Society (AHS) this week in Washington, DC. | 03 June 2011 |
| Hearing / Deafness News | |
| House Research Institute Family Camp Offers Weekend Of Fun For Children With Hearing Loss And Their Families Celebrating its' 26th anniversary, House Research Institute's Family Camp continues to be a popular program for many families who have a child with a hearing loss. The camp is once again filled to capacity setting an attendance record. | 03 June 2011 |
| Heart Disease News | |
| Stopping Heart Disease In Cancer Patients Before It Starts Researchers in the Faculty of Medicine & Dentistry are trying to reverse a devastating trend: cancer survivors developing cardiovascular disease, one of the top two killers in Canada.Ian Paterson, an assistant professor of cardiology at the University of Alberta and Edie Pituskin, a registered nurse and PhD candidate in the Faculty of Rehabilitation Medicine, are starting what is called the MANTICORE clinical trials. | 03 June 2011 |
| Scientists Discover Gene Regulator That Helps Hearts Through Exercise Providing a medical explanation for why exercise is good for the heart, a team of scientists from Brazil pursuing a study that started in Dr. Ian Phillips' lab at Keck Graduate Institute (KGI) has discovered a new gene regulator called MicroRNA 29 that keeps hearts healthy even under intense exercise. | 03 June 2011 |
| No Cancer Risk With Angiotensin Receptor Blockers Angiotensin receptor blockers (ARBs) do not increase cancer risk, the FDA reported, after investigating the blood pressure medications following a study last year suggesting there might be a small risk. | 03 June 2011 |
| HIV / AIDS News | |
| 5th June 2011 Marks 30 Years Of AIDS, UK HIV and sexual health charity Terrence Higgins Trust is marking the 30th anniversary of the first AIDS cases in the USA this Sunday, 5th June, with its Walk for Life event in aid of people living with HIV. | 03 June 2011 |
| Low Cost Trumps Effectiveness In PrEP Acceptance In a recent clinical trial, non-HIV-infected individuals who used the antiretroviral drug Truvada on a daily basis cut their risk of becoming infected with HIV by 44 percent. While the findings are reason for great optimism, researchers say it is now important to understand the factors that could influence the public's willingness to use the drug in this way, known as pre-exposure prophylaxis, or PrEP. | 03 June 2011 |
| 25% Drop In New HIV Infections Between 2001 And 2009 Worldwide Between 2001 and 2009 the number of new HIV infections per year dropped almost 25%, according to UNAIDS, the Joint United Nations Program on HIV/AIDS. During this period India's annual rate went down by over 50%, and 35% in South Africa. | 03 June 2011 |
| Global AIDS Response Continues To Show Results As A Record Number Of People Access Treatment And Rates Of New HIV Infections Fall By Nearly 25% About 6.6 million people were receiving antiretroviral therapy in low- and middle-income countries at the end of 2010, a nearly 22-fold increase since 2001, according to a new report AIDS at 30: Nations at the crossroads, released today by the Joint United Nations Programme on HIV/AIDS (UNAIDS). | 03 June 2011 |
| Study Examines Sexual Communication In Transgender Community A new study from North Carolina State University shows that talking about safer sex is a complicated process for individuals in the transgender community. The finding may help efforts to promote safer sex practices in a community facing high HIV rates - and also sheds light on broader questions related to safer sex for everyone. | 03 June 2011 |
| FSU Scientist Leads Research On AIDS-Related Cancer In the early days of the AIDS epidemic, a once-rare form of cancer known as Kaposi's sarcoma (KS) emerged as a frequent harbinger of HIV. Its stigma was best illustrated by Tom Hanks, who portrayed a gay man trying to conceal the cancerous skin lesions from his co-workers in the 1993 movie "Philadelphia. | 03 June 2011 |
| Huntingtons Disease News | |
| Discovery Of Drug Candidate For Alzheimer's, Huntington's Disease Scientists at the Gladstone Institutes have identified a drug candidate that diminishes the effects of both Alzheimer's disease and Huntington's disease in animal models, offering new hope for patients who currently lack any medications to halt the progression of these two debilitating illnesses. | 03 June 2011 |
| Huntington's Disease Breakthrough Announced By Trans-Atlantic Team Medical researchers may have uncovered a novel approach to treat an incurable and ultimately fatal neurodegenerative disease that affects hundreds of thousands of people.Two international studies, one led by the University of Leicester, and the other a collaboration with Leicester led by scientists in the USA, hold out promise for slowing down the development of Huntington's disease - and potentially, Alzheimer's and Parkinson's diseases. | 03 June 2011 |
| Hypertension News | |
| The Role Of Vitamin D In African-Americans With High Blood Pressure To Be Studied By Wayne State A Wayne State University School of Medicine physician researcher has received a $1.9 million National Institutes of Health grant to study the role of vitamin D in halting and reducing subclinical cardiac damage in African-Americans suffering from high blood pressure. | 03 June 2011 |
| FDA: Treatment With Angiotensin Receptor Blockers For High Blood Pressure Does Not Increase Risk Of Cancer The U.S. Food and Drug Administration today announced that a group of medications used to control high blood pressure, called angiotensin receptor blockers (ARBs), do not increase the risk of developing cancer in patients using the medications. | 03 June 2011 |
| No Cancer Risk With Angiotensin Receptor Blockers Angiotensin receptor blockers (ARBs) do not increase cancer risk, the FDA reported, after investigating the blood pressure medications following a study last year suggesting there might be a small risk. | 03 June 2011 |
| Immune System / Vaccines News | |
| IBio Announces Positive H1N1 Influenza Vaccine Clinical Trial Results iBio, Inc. (NYSE AMEX: IBIO) today announced positive interim results from a Phase 1 clinical trial of an iBioLaunch™ platform-produced subunit vaccine directed against Influenza A/California/04/09 (H1N1). | 03 June 2011 |
| Health Benefit Of Green Tea: Mechanism Discovered, New Approach To Autoimmune Disease One of the beneficial compounds found in green tea has a powerful ability to increase the number of "regulatory T cells" that play a key role in immune function and suppression of autoimmune disease, according to new research in the Linus Pauling Institute at Oregon State University. | 03 June 2011 |
| Experimental Vaccine Made From Frozen Immune Cells Shows Promise For Prostate Cancer Patients Metastatic prostate cancer patients who received an investigational vaccine made from their own frozen immune cells lived 10 months longer than those not treated with it, according to data being presented by researchers from the Kimmel Cancer Center at Jefferson at the 2011 American Society of Clinical Oncology annual meeting in Chicago on Saturday, June 4. | 03 June 2011 |
| Cholera Vaccination Strategies For Zimbabwe Suggested By UF Researchers Mathematical models analyzing how a cholera outbreak spread in Zimbabwe are providing new insights into the most effective vaccination strategies for preventing future cholera epidemics, according to University of Florida researchers. | 03 June 2011 |
| Infectious Diseases / Bacteria / Viruses News | |
| Features Of Bacteria That Caused Epidemic E. Coli In Europe Revealed By Genomics Analysis An outbreak of E. coli infection was detected in Germany about two weeks ago. Health authorities say that over 1500 people have become infected and 17 have died so far. Cases of E. coli infection have been reported in several other European countries, including the UK, the Netherlands, Sweden, Denmark, France, Norway, Spain and Switzerland. | 03 June 2011 |
| Discovery Of New MRSA Strain In Milk, UK A new strain of meticillin-resistant Staphylococcus aureus (MRSA) has been discovered by scientists at the University of Cambridge Veterinary School. The findings are published today in the journal The Lancet Infectious Diseases. | 03 June 2011 |
| Tips And Resources On Foodborne Illness As European Outbreak Of E. Coli Points To Importance Of Safe Food Handling For consumers in the United States concerned by the outbreak of E. coli in Europe, the American College of Gastroenterology offers background on foodborne illness, tips for food safety, and expert insight from its resources on digestive health on what to do in the case of foodborne illness. | 03 June 2011 |
| Haiti: An Alarming Resurgence Of Cholera The cholera epidemic in Haiti is far from over, with a sharp increase in cases seen in the capital, Port-au-Prince, and outbreaks reported elsewhere in the country, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) said today. | 03 June 2011 |
| iFyber Scientists Publish Research On Antimicrobial Coatings In Leading Scientific Journal iFyber researchers have published an article in the peer-reviewed journal Advanced Functional Materials that reports the antimicrobial characteristics of copper coatings on fiber substrates designed for wound care products. | 03 June 2011 |
| Low Cost Trumps Effectiveness In PrEP Acceptance In a recent clinical trial, non-HIV-infected individuals who used the antiretroviral drug Truvada on a daily basis cut their risk of becoming infected with HIV by 44 percent. While the findings are reason for great optimism, researchers say it is now important to understand the factors that could influence the public's willingness to use the drug in this way, known as pre-exposure prophylaxis, or PrEP. | 03 June 2011 |
| Fraunhofer USA CMB Announces Positive Phase 1 Interim Results For Its Plant-Produced H1N1 Influenza Vaccine Fraunhofer USA Center for Molecular Biotechnology (CMB), a not-for-profit, Delaware-based organization focused on developing a proprietary plant-based protein production platform and its applications in vaccine and therapeutic fields, today announced positive interim results from the first human trial of plant-produced H1N1 influenza vaccine (HAC1) that began on September 13, 2010. | 03 June 2011 |
| As E Coli Outbreak In Germany Continues, Experts Are Concerned About Pressure On Health Facilities, Antibiotic Resistance And Preparedness Across EU As the current virulent Shiga toxin-producing Escherichia coli (STEC) outbreak in Germany spreads, experts from The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) are concerned not only about the pressure health facilities are being put under, but also the use of antibiotics and broader implications for preparedness across Europe to cope, both now and in the future. | 03 June 2011 |
| E. Coli Outbreak, Spain And Germany Seek European Level Aid For Spanish Farmers Spanish vegetable exporters mistakenly got the blame for the E. coli outbreak that has caused over 1,064 cases of bloody diarrhea and 470 cases of HUS (hemolytic-uremic syndrome) in Germany and some other European countries. | 03 June 2011 |
| New MRSA Variant Detected In Cow's Milk Can Evade Some Existing Detection Methods; Study Reveals Evidence That Cows Could Be A Source Of Human MRSA An Article published Online First by The Lancet Infectious Diseases reports detection of a new variant of meticilin-resistant Staphylococcus aureus in cow's milk-genetically different to existing MRSA strains-from the UK and Denmark. | 03 June 2011 |
| Research Suggests That Eating Dirt Can Be Good For The Belly Most of us never considered eating the mud pies we made as kids, but for many people all over the world, dining on dirt is nothing out of the ordinary. Now an extensive meta-analysis forthcoming in the June issue of The Quarterly Review of Biology helps explain why. | 03 June 2011 |
| New Strategy To Combat Cystitis One in three women will be faced at least once in her life with cystitis, for some the start of a constantly recurring infection. Cystitis is caused by Escherichia coli bacteria which fasten on to the wall of the bladder by means of thread-like structures (pili). | 03 June 2011 |
| Copper Proves Effective Against New E. coli Strains As the World Health Organisation suggests the E. coli outbreak in Germany is a strain never before seen in an outbreak - O104:H4 - laboratory science conducted at the University of Southampton indicates a role for copper in preventing the spread of such infections. | 03 June 2011 |
| Genome Sequence Identifies Super-Toxic Bacteria As Cause Of The Current European Epidemic The recent outbreak of an E. coli infection in Germany has resulted in serious concerns about the potential appearance of a new deadly strain of bacteria. In response to this situation, and immediately after the reports of deaths, the University Medical Centre Hamburg-Eppendorf and BGI-Shenzhen began working together to sequence the bacterium and assess its human health risk. | 03 June 2011 |
| DNA Sequencing Data Reveals New Hybrid E. Coli Strain Is Cause Of German Outbreak Life Technologies Corporation announced that preliminary data from DNA sequencing performed in cooperation with the University Hospital Muenster, Germany, on the Ion Personal Genome Machine (PGM™) strongly suggests that the bacterium at the root of the deadly outbreak in Germany is a new hybrid type of pathogenic E. | 03 June 2011 |
| IT / Internet / E-mail News | |
| Cholera Vaccination Strategies For Zimbabwe Suggested By UF Researchers Mathematical models analyzing how a cholera outbreak spread in Zimbabwe are providing new insights into the most effective vaccination strategies for preventing future cholera epidemics, according to University of Florida researchers. | 03 June 2011 |
| At SIIM 2011 Siemens Showcases Imaging IT Solutions For Driving Greater Value In Radiology And Other Specialties Siemens Healthcare will showcase its portfolio of imaging information technology (IT) and workflow management solutions at the Society for Imaging Informatics in Medicine (SIIM) 2011 Annual Meeting from June 2-5, 2011, (booth 825) in the Gaylord National Resort and Convention Center, Washington, D. | 03 June 2011 |
| Liver Disease / Hepatitis News | |
| Hepatitis C Outcomes Improved Using Videoconferencing Widely-available technology, expert training and real-time feedback helped ensure that patients treated for Hepatitis C in local communities did as well as patients treated at a university-based medical center, results of a new study funded by HHS' Agency for Healthcare Research and Quality show. | 03 June 2011 |
| Lung Cancer News | |
| Celgene And Acceleron Initiate Phase 2/3 Study Of ACE-011 (Sotatercept) To Treat Chemotherapy-Induced Anemia In Patients With Lung Cancer Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases, and Celgene Corporation (NASDAQ: CELG) today announced the initiation of the first part of a Phase 2/3 clinical study of ACE-011 (sotatercept) for the treatment of chemotherapy-induced anemia (CIA) in patients with metastatic non-small cell lung cancer (NSCLC). | 03 June 2011 |
| Personalised First-Line Therapy Stalls Lung Cancer For Nearly Twice As Long As Chemotherapy Roche today announced results from the first Phase III study with erlotinib (Tarceva®) in Western patients with a genetically mutated type of advanced non-small cell lung cancer (NSCLC). Results showed that first-line treatment with erlotinib nearly doubled the time people with advanced NSCLC with a specific genetic mutation lived without their disease getting worse compared with chemotherapy (median progression-free survival or PFS: 9. | 03 June 2011 |
| Survival In Refractory Lung Cancer Patients Extended By Drug Combination Scientists have identified a drug combination, when used in advanced lung cancer patients, shows a survival advantage in patients who no longer respond to existing therapies. They found that bexarotene and erlotinib can each repress the critical cell cycle regulator: cyclin D1. | 03 June 2011 |
| Lymphoma / Leukemia / Myeloma News | |
| New Therapy For Blood Cancers Develolped Clinical researchers at VCU Massey Cancer Center have successfully completed a Phase I clinical trial evaluating a combination of the drugs Bortezomib and Alvocidib in patients with relapsed or refractory blood cancers, paving the way for a Phase II clinical trial to test the safety and effectiveness of the new therapy. | 03 June 2011 |
| One Step Closer To A Stem Cell Treatment To Prevent Leukemia Returning Researchers at King's College London have identified a way of eliminating leukaemic stem cells, which could lead to new treatments that may enable complete remission for leukaemia patients. An early study in mice has shown that leukaemic stem cells can be abolished by suppressing two proteins found in the body. | 03 June 2011 |
| Medical Devices / Diagnostics News | |
| Animas(R) Vibe™, The First Integrated Offering From Animas Corporation And Dexcom, Inc., Receives European CE Mark Approval Animas Corporation announced today the receipt of CE Mark approval for Animas® Vibe™, the first and only continuous glucose monitoring (CGM)-enabled insulin pump system with Dexcom G4™ CGM technology. | 03 June 2011 |
| ORTHOCON®, Inc. Receives 510(k) Clearance To Market HEMASORB Apply™ ORTHOCON®, Inc., a privately-held therapeutic device company, announced that the Food and Drug Administration cleared HEMASORB Apply™ for clinical use and sale in the United States. | 03 June 2011 |
| New Device Offers Revolutionary Treatment For Difficult-to-Treat Brain Aneurysms Physicians at Rush University Medical Center are offering a new and effective treatment to patients suffering from complex brain aneurysms. The recently FDA-approved technology called the Pipeline Embolization Device (PED gives doctors the ability for the very first time to treat some of the most complex and dangerous brain aneurysms using minimally invasive techniques. | 03 June 2011 |
| Medical Students / Training News | |
| New Online Training Program To Tackle Pain, Australia A new online educational program will be developed to help GPs treat chronic and acute pain, which is a growing problem affecting millions of Australians and costing the economy billions each year. | 03 June 2011 |
| Bill Creating Medical School Scholarships Passes Assembly Assembly Bill 589 (Perea) passed the Assembly today with a 63-10 vote. Sponsored by the California Medical Association (CMA), the bill establishes, within the Health Professions Education Foundation, the Steven M. | 03 June 2011 |
| Medicare / Medicaid / SCHIP News | |
| Major New Effort To Give Consumers And Employers Better Information About Quality Of Care The Centers for Medicare & Medicaid Services (CMS) today proposed rules that will enable consumers and employers to select higher-quality, lower-cost physicians, hospitals and other health care providers in their area. | 03 June 2011 |
| Supportive Of Intent Of ACO Proposed Rule, ACP Expresses Concern That Program Sets Bar Too High For Many Internal Medicine Physicians The American College of Physicians (ACP) comment on: Medicare Program; Medicare Shared Savings Program: Accountable Care Organizations and MedicareProgram: Waiver Designs in Connection With the Medicare Shared Savings Program and the Innovation Center; Proposed Rule and Notice In a 10-page letter addressed to Donald Berwick, administrator of the Centers for Medicare and Medicaid Services, ACP today said: The ACP strongly supports the intent of the proposed rule, and believes that an ACO model has the potential of supporting such important care delivery goals as enhancing quality, efficiency, integration, and patient-centeredness. | 03 June 2011 |
| Melanoma / Skin Cancer News | |
| Plexxikon Announces Combination Trials For Vemurafenib In Melanoma Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced new clinical trials in metastatic melanoma testing vemurafenib (PLX4032/RG7204) in combination with other state-of-the-art treatments, including an immunologic therapy and an investigational MEK inhibitor. | 03 June 2011 |
| Bristol Myers, Roche Combine Know How; Combat Melanoma There are several ways to combat deadly melanoma. One way is to attack the cancer by bolstering the body's immune system to fight the disease. Another way is to block a genetic mutation known as BRAF, which may help the disease grow. | 03 June 2011 |
| Morphotek®, Inc. Announces Initiation Of MORAb-004 Phase II Study In Melanoma Morphotek®, Inc., a subsidiary of Eisai Inc., announced that it has commenced a multi-center, phase II study of MORAb-004 for the treatment of metastatic melanoma. The study will evaluate MORAb-004, a potentially first-in-class monoclonal antibody that specifically binds to endosialin/tumor endothelial marker-1 (TEM-1), as a single agent therapy comparing its safety and therapeutic activity at two dosages. | 03 June 2011 |
| Mental Health News | |
| Suicide Prevention NYC Overnight Walk This Weekend; Facts, Figures Suicide is a serious national and global health problem that cuts across all ages and demographics. The American Foundation for Suicide Prevention (AFSP) plans to hold its Out of the Darkness Overnight walk in New York City on June 4th through 5th. | 03 June 2011 |
| Depression And Negative Thoughts We all have our ups and downs-a fight with a friend, a divorce, the loss of a parent. But most of us get over it. Only some go on to develop major depression. Now, a new study, which will be published in an upcoming issue of Psychological Science, a journal of the Association for Psychological Science, suggests part of the reason may be that people with depression get stuck on bad thoughts because they're unable to turn their attention away. | 03 June 2011 |
| Could The Legal Concept Of Criminal Responsibility Be Challenged By Neuroscience? Just before 10:00 a.m. on June 20, 2001, a uniformed police officer was dispatched to do what he thought was a routine welfare check at a home in Houston, Texas. When the officer met Andrea Yates at the door, she immediately told him, "I just killed my kids. | 03 June 2011 |
| MRI / PET / Ultrasound News | |
| The World Leader In Molecular Breast Imaging To Premiere Largest Detector In The Industry Dilon Diagnostics will introduce the latest advancement in molecular breast imaging (MBI) this week at the Society of Nuclear Medicine (SNM) Meeting in San Antonio, Texas, with the premiere of its FDA-cleared Dilon 6800® Acella Gamma Camera system. | 03 June 2011 |
| MRSA / Drug Resistance News | |
| Discovery Of New MRSA Strain In Milk, UK A new strain of meticillin-resistant Staphylococcus aureus (MRSA) has been discovered by scientists at the University of Cambridge Veterinary School. The findings are published today in the journal The Lancet Infectious Diseases. | 03 June 2011 |
| New MRSA Staph Strand Found In UK Cows; Pasteurized Milk Is Safe A new variant of meticilin-resistant Staphylococcus aureus found in cow's milk is genetically different to existing MRSA strains from the United Kingdom (UK). The original scare had Europeans not drinking milk, but a released study mentions that cows may simply be hosts to this new strand and normal processes of milk, such as pasteurization, will kill any risk to humans. | 03 June 2011 |
| New MRSA Variant Detected In Cow's Milk Can Evade Some Existing Detection Methods; Study Reveals Evidence That Cows Could Be A Source Of Human MRSA An Article published Online First by The Lancet Infectious Diseases reports detection of a new variant of meticilin-resistant Staphylococcus aureus in cow's milk-genetically different to existing MRSA strains-from the UK and Denmark. | 03 June 2011 |
| Hospitalized Patients With New Type Of MRSA, Probably Of Animal Origin A distinctly new type of methicillin resistant Staphylococcus aureus (MRSA) that is not detected by traditional genetic screening methods has been discovered in patients in Irish hospitals according to research to be published in the journal Antimicrobial Agents and Chemotherapy. | 03 June 2011 |
| Genome Sequence Identifies Super-Toxic Bacteria As Cause Of The Current European Epidemic The recent outbreak of an E. coli infection in Germany has resulted in serious concerns about the potential appearance of a new deadly strain of bacteria. In response to this situation, and immediately after the reports of deaths, the University Medical Centre Hamburg-Eppendorf and BGI-Shenzhen began working together to sequence the bacterium and assess its human health risk. | 03 June 2011 |
| Multiple Sclerosis News | |
| Teva Completes Enrollment In Phase III Multiple Sclerosis Trial Evaluating Glatiramer Acetate Three Times Weekly Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today announced completion of patient enrollment for the GALA (Glatiramer Acetate Low-frequency Administration) trial. This international Phase III trial in patients with relapsing-remitting multiple sclerosis (RRMS), is designed to examine the efficacy, safety and tolerability of 40mg COPAXONE® (glatiramer acetate injection) administered three times a week compared to placebo. | 03 June 2011 |
| Promising New Approach To Autoimmune Diseases Researchers from Harvard Medical School and MIT have developed a new approach for identifying the "self" proteins targeted in autoimmune diseases such as multiple sclerosis, diabetes and rheumatoid arthritis. | 03 June 2011 |
| Neurology / Neuroscience News | |
| Seaside Therapeutics Initiates Pivotal Phase 3 Study Of STX209 In Fragile X Syndrome Seaside Therapeutics, Inc. announced today the initiation of a randomized, double-blind, placebo-controlled Phase 3 study to evaluate the effects of STX209 (arbaclofen) on social impairment in adolescents and adults (ages 12 to 25) with fragile X syndrome. | 03 June 2011 |
| For Ion Channels A Small Change Makes A Big Difference Using a high-resolution single-molecule study technique, University of Illinois researchers have seen the very subtle differences between two branches of an important family of neurotransmitter-gated ion channels. | 03 June 2011 |
| Wealthier Patients Living Longer Than Poorer Patients With Glioblastoma Survival rates of wealthier patients and those younger than 70 with glioblastoma, the most common and aggressive malignant brain tumor, have improved since 2000, whereas rates for those living in poorer areas and older than 70 have remained stagnant, according to an abstract being presented at the American Society of Clinical Oncology annual meeting in Chicago by Thomas Jefferson University Hospital researchers on Saturday, June 4. | 03 June 2011 |
| New Adult Model Of Rett Syndrome An IRSF funded study published in the journal Science has shown that the childhood disorder Rett syndrome, can be reestablished in adult animals by "switching off" a critical disease causing gene in healthy adult animals. | 03 June 2011 |
| Could The Legal Concept Of Criminal Responsibility Be Challenged By Neuroscience? Just before 10:00 a.m. on June 20, 2001, a uniformed police officer was dispatched to do what he thought was a routine welfare check at a home in Houston, Texas. When the officer met Andrea Yates at the door, she immediately told him, "I just killed my kids. | 03 June 2011 |
| Head Injuries Can Lead To An Increase In Violent Behavior Young people who have sustained a head injury during their lifetime are more likely to engage in violent behavior, according to an eight-year study from the University of Michigan School of Public Health. | 03 June 2011 |
| Discovery Of Drug Candidate For Alzheimer's, Huntington's Disease Scientists at the Gladstone Institutes have identified a drug candidate that diminishes the effects of both Alzheimer's disease and Huntington's disease in animal models, offering new hope for patients who currently lack any medications to halt the progression of these two debilitating illnesses. | 03 June 2011 |
| The Adult Brain Requires MeCP2 For Proper Functioning A paper published online in Science provides evidence that the Methyl-CpG-Binding Protein 2 (MeCP2) is required throughout life to maintain healthy brain function. The findings are reported from the Baylor College of Medicine lab of Huda Zoghbi, HHMI investigator and Director of the Jan and Dan Duncan Neurological Research Institute. | 03 June 2011 |
| Taking Advantage Of The High Iron Requirements Of Brain Cancer Cells To Improve Treatment Brain cancer therapy may be more effective if the expression of an iron-storing protein is decreased to enhance the action of therapeutic drugs on brain cancer cells, according to Penn State College of Medicine researchers. | 03 June 2011 |
| Rett Protein Needed For Adult Neuron Function The protein MeCP2 is porridge to the finicky neuron. Like Goldilocks, the neuron or brain cell needs the protein in just the right amount. Girls born with dysfunctional MeCP2 (methyl-CpG-binding protein 2) develop Rett syndrome, a neurological disorder. | 03 June 2011 |
| New Device Offers Revolutionary Treatment For Difficult-to-Treat Brain Aneurysms Physicians at Rush University Medical Center are offering a new and effective treatment to patients suffering from complex brain aneurysms. The recently FDA-approved technology called the Pipeline Embolization Device (PED gives doctors the ability for the very first time to treat some of the most complex and dangerous brain aneurysms using minimally invasive techniques. | 03 June 2011 |
| Nursing / Midwifery News | |
| ACO Proposed Rule Needs More Focus On Nursing Contributions The American Nurses Association (ANA) encouraged significant changes to the Centers for Medicare and Medicaid Services' (CMS) proposed rule for Accountable Care Organizations (ACOs). ANA's recommendations maximize patient care and create greater efficiencies and savings by articulating professional nursing's impact on areas of leadership, patient-centered care coordination, and quality. | 03 June 2011 |
| Nutrition / Diet News | |
| FDA Seizes Elderberry Juice Concentrate At Kansas Company At the request of the U.S. Food and Drug Administration, U.S Marshals seized elderberry juice products that have been distributed by Wyldewood Cellars Inc., based in Peck, Kan., because the products are unapproved and misbranded drugs. | 03 June 2011 |
| Tips And Resources On Foodborne Illness As European Outbreak Of E. Coli Points To Importance Of Safe Food Handling For consumers in the United States concerned by the outbreak of E. coli in Europe, the American College of Gastroenterology offers background on foodborne illness, tips for food safety, and expert insight from its resources on digestive health on what to do in the case of foodborne illness. | 03 June 2011 |
| New MyPlate Dietary Guidance Will Dramatically Transform How Americans Eat MyPlate, the dietary guidance icon released today by USDA, will revolutionize how Americans conceptualize and plan daily meals, including a landmark recommendation that each meal include half a plate of fruits and vegetables. | 03 June 2011 |
| E. Coli Outbreak, Spain And Germany Seek European Level Aid For Spanish Farmers Spanish vegetable exporters mistakenly got the blame for the E. coli outbreak that has caused over 1,064 cases of bloody diarrhea and 470 cases of HUS (hemolytic-uremic syndrome) in Germany and some other European countries. | 03 June 2011 |
| Health Benefit Of Green Tea: Mechanism Discovered, New Approach To Autoimmune Disease One of the beneficial compounds found in green tea has a powerful ability to increase the number of "regulatory T cells" that play a key role in immune function and suppression of autoimmune disease, according to new research in the Linus Pauling Institute at Oregon State University. | 03 June 2011 |
| How A High-Fat Diet During Pregnancy Increases The Risk Of Stillbirth Eating a high-fat diet during pregnancy increases the chance of stillbirth, according to new research at Oregon Health & Science University. The new data show eating a typical American diet, which is high in fat, decreases blood flow from the mother to the placenta, the temporary organ that nourishes the unborn fetus. | 03 June 2011 |
| The Role Of Vitamin D In African-Americans With High Blood Pressure To Be Studied By Wayne State A Wayne State University School of Medicine physician researcher has received a $1.9 million National Institutes of Health grant to study the role of vitamin D in halting and reducing subclinical cardiac damage in African-Americans suffering from high blood pressure. | 03 June 2011 |
| Beef: America's Favorite Protein Is An Essential Building Block The new visual icon released by the U.S. Department of Agriculture (USDA) and the Department of Health and Human Services (HHS), called MyPlate, offers simple and actionable steps to build healthier diets. | 03 June 2011 |
| Discovery Of Bitter Blocker Increases Understanding Of Taste, Opening Doors To Better Nutrition And Therapeutic Compliance Although bitterness can sometimes be desirable - such as in the taste of coffee or chocolate - more often bitter taste causes rejection that can interfere with food selection, nutrition and therapeutic compliance. | 03 June 2011 |
| New Studies Reinforce Benefits Of Drinking Lowfat Chocolate Milk After A Tough Workout New research suggests an effective recovery drink may already be in your refrigerator: lowfat chocolate milk. Grabbing lowfat chocolate milk after a tough workout helped give both trained and amateur athletes a post-exercise training advantage, according to three new studies presented at the American College of Sports Medicine and published in the Journal of Strength and Conditioning Research this month. | 03 June 2011 |
| Children Eat More Vegetables When Allowed To Choose A study conducted at the University of Granada has proved that children eat up to 80 percent more vegetables when they are allowed to choose. Researchers have also found that the bitterness of calcium which is noticeably present in vegetables such as spinachs, collard greens cabbage, onions, chard or broccoli can be a factor negatively influencing children's consumption of vegetables. | 03 June 2011 |
| Obesity / Weight Loss / Fitness News | |
| Weight Loss In A 3D Virtual World Participants in two weight-loss programs -- one involving traditional health club sessions and the other delivered online in a 3D virtual world -- lost similar amounts of weight and body fat, but the online contingent reported significantly greater gains in behaviors that could help them live healthier and leaner lives. | 03 June 2011 |
| How A High-Fat Diet During Pregnancy Increases The Risk Of Stillbirth Eating a high-fat diet during pregnancy increases the chance of stillbirth, according to new research at Oregon Health & Science University. The new data show eating a typical American diet, which is high in fat, decreases blood flow from the mother to the placenta, the temporary organ that nourishes the unborn fetus. | 03 June 2011 |
| Pain / Anesthetics News | |
| Workers' Compensation Update: Chiropractic Care More Valuable And Cost-Efficient For Low Back Pain Vs. Physician Care, Physical Therapy A recent study conducted by medical and healthcare professionals outside the chiropractic profession, "Health Maintenance Care in Work-Related Low Back Pain and Its Association with Disability Recurrence," (Journal of Occupational and Environmental Medicine, April 2011, Vol. | 03 June 2011 |
| Hip Strengthening Exercises Improved Running Mechanics, Lessened Knee Pain Hip strengthening exercises performed by female runners not only significantly reduced patellofemoral pain - a common knee pain experienced by runners - but they also improved the runners' gaits, according to Indiana University motion analysis expert Tracy Dierks. | 03 June 2011 |
| New Online Training Program To Tackle Pain, Australia A new online educational program will be developed to help GPs treat chronic and acute pain, which is a growing problem affecting millions of Australians and costing the economy billions each year. | 03 June 2011 |
| Two Minutes Of Exercise A Day Can Keep The Pain Away As little as two minutes of exercise a day can reduce pain and tenderness in adults with neck and shoulder problems, according to research being presented today at the 58th Annual Meeting of the American College of Sports Medicine and 2nd World Congress on Exercise is Medicine®. | 03 June 2011 |
| Parkinson's Disease News | |
| Huntington's Disease Breakthrough Announced By Trans-Atlantic Team Medical researchers may have uncovered a novel approach to treat an incurable and ultimately fatal neurodegenerative disease that affects hundreds of thousands of people.Two international studies, one led by the University of Leicester, and the other a collaboration with Leicester led by scientists in the USA, hold out promise for slowing down the development of Huntington's disease - and potentially, Alzheimer's and Parkinson's diseases. | 03 June 2011 |
| Pediatrics / Children's Health News | |
| Children And Depression From a distance, Callie (not her real name) appears to be a normal if quiet 5-year-old girl. But when faced with a toy that blows large soap bubbles - an activity that makes the vast majority of kindergarteners squeal and leap with delight - she is uninterested in popping the bubbles or taking a turn with the gun herself. | 03 June 2011 |
| Discovery Of Bitter Blocker Increases Understanding Of Taste, Opening Doors To Better Nutrition And Therapeutic Compliance Although bitterness can sometimes be desirable - such as in the taste of coffee or chocolate - more often bitter taste causes rejection that can interfere with food selection, nutrition and therapeutic compliance. | 03 June 2011 |
| Head Injuries Can Lead To An Increase In Violent Behavior Young people who have sustained a head injury during their lifetime are more likely to engage in violent behavior, according to an eight-year study from the University of Michigan School of Public Health. | 03 June 2011 |
| AAP Statement On House Appropriations Committee Acceptance Of FDA Amendment By: O. Marion Burton, MD, FAAP, president, American Academy of Pediatrics "The American Academy of Pediatrics is profoundly disappointed with the U.S. House Appropriations Committee for accepting an amendment yesterday that will severely limit the basic authority of the Food and Drug Administration (FDA) over a variety of public health protections for children. | 03 June 2011 |
| Toddlers At Risk For Autism Identified By Autism Experts/Pediatricians Partnership Parents and health care providers can't always tell whether toddlers display signs of autism syndrome disorder (ASD), but new research from the University of Utah shows that a significant portion of at-risk children between 14-24 months can be identified through systematic screening by autism experts and providers working together. | 03 June 2011 |
| The Adult Brain Requires MeCP2 For Proper Functioning A paper published online in Science provides evidence that the Methyl-CpG-Binding Protein 2 (MeCP2) is required throughout life to maintain healthy brain function. The findings are reported from the Baylor College of Medicine lab of Huda Zoghbi, HHMI investigator and Director of the Jan and Dan Duncan Neurological Research Institute. | 03 June 2011 |
| Rett Protein Needed For Adult Neuron Function The protein MeCP2 is porridge to the finicky neuron. Like Goldilocks, the neuron or brain cell needs the protein in just the right amount. Girls born with dysfunctional MeCP2 (methyl-CpG-binding protein 2) develop Rett syndrome, a neurological disorder. | 03 June 2011 |
| Children Eat More Vegetables When Allowed To Choose A study conducted at the University of Granada has proved that children eat up to 80 percent more vegetables when they are allowed to choose. Researchers have also found that the bitterness of calcium which is noticeably present in vegetables such as spinachs, collard greens cabbage, onions, chard or broccoli can be a factor negatively influencing children's consumption of vegetables. | 03 June 2011 |
| Pharma Industry / Biotech Industry News | |
| Care Act Builds On Manufacturing Industry Efforts To Ensure Safe And Effective Medical Imaging Services The Medical Imaging & Technology Alliance (MITA) voiced its support today for the "Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2011," introduced yesterday by Representatives Ed Whitfield (R-KY) and John Barrow (D-GA). | 03 June 2011 |
| Advances In Novel Protein Kinase Inhibitor Development Biotech scientists are working on novel protein kinase inhibitors that are targeting a host of conditions ranging from atherosclerosis to neurodegenerative diseases, reports Genetic Engineering & Biotechnology News (GEN). | 03 June 2011 |
| Multidisciplinary Collaboration For Sustainable Innovation Last year, Nature published an interview with Gary Pisano, Professor of Business Administration at the Harvard Business School, which briefly stated that the next ten years will witness an acceleration of the profound changes in drug research and development, competition, and government policies. | 03 June 2011 |
| ORTHOCON®, Inc. Receives 510(k) Clearance To Market HEMASORB Apply™ ORTHOCON®, Inc., a privately-held therapeutic device company, announced that the Food and Drug Administration cleared HEMASORB Apply™ for clinical use and sale in the United States. | 03 June 2011 |
| ThermoGenesis Announces 510(k) Approval For Use Of Res-Q In Preparation Of Platelet Rich Plasma ThermoGenesis Corp. (NASDAQ: KOOL), a leading supplier of innovative products and services that process and store adult stem cells, said it has received FDA clearance of its 510(k) submission for the use of its Res-Q™ 60 (Res-Q) System technology to be used for the safe and rapid preparation of autologous platelet rich plasma (PRP) from a small sample of blood at the patient's point-of-care. | 03 June 2011 |
| Morphotek®, Inc. Announces Initiation Of MORAb-004 Phase II Study In Melanoma Morphotek®, Inc., a subsidiary of Eisai Inc., announced that it has commenced a multi-center, phase II study of MORAb-004 for the treatment of metastatic melanoma. The study will evaluate MORAb-004, a potentially first-in-class monoclonal antibody that specifically binds to endosialin/tumor endothelial marker-1 (TEM-1), as a single agent therapy comparing its safety and therapeutic activity at two dosages. | 03 June 2011 |
| Spherix Drug Candidate SPX-106 Shows Statistically Significant Reductions In Serum Triglycerides In Preclinical Testing Spherix Incorporated (NASDAQ: SPEXD) -- an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies -- today announced that its drug candidate, SPX-106, achieved statistically significant reductions in triglycerides and cholesterol when administered in combination with D-tagatose for nine weeks to genetically engineered mice prone to dyslipidemia. | 03 June 2011 |
| Pharmacy / Pharmacist News | |
| Pfizer And Hisun Sign MOU To Increase Access To Quality And Low-Cost Medicines For Patients In China Pfizer Inc. (NYSE: PFE) and Zhejiang Hisun Pharmaceuticals (SSE stock code 600267), a leading pharmaceutical company in China, today jointly announced the signing of a memorandum of understanding (MOU) on their intention to establish a joint venture. | 03 June 2011 |
| Pregnancy / Obstetrics News | |
| How A High-Fat Diet During Pregnancy Increases The Risk Of Stillbirth Eating a high-fat diet during pregnancy increases the chance of stillbirth, according to new research at Oregon Health & Science University. The new data show eating a typical American diet, which is high in fat, decreases blood flow from the mother to the placenta, the temporary organ that nourishes the unborn fetus. | 03 June 2011 |
| Preventive Medicine News | |
| Help Prevent Overexertion Injuries At Work And At Home The National Safety Council on June 5 will launch its "Preventing Overexertion" Week as part of National Safety Month, an annual observance to educate about the top causes of preventable injuries and deaths. | 03 June 2011 |
| Physicians Discover How Cancer Drug Works To Help Prevent Recurrent Kidney Disease A collaboration of Miller School physicians, surgeons and scientists has unlocked the mechanism of a drug used to prevent recurrent kidney disease. The finding, which has implications for the diagnosis and treatment of many other diseases, involves the action of rituximab, a B-cell lymphoma therapy, in treating recurrent focal segmental glomerulosclerosis (FSGS) in children and young adults. | 03 June 2011 |
| Primary Care / General Practice News | |
| RACGP Committed To Supporting Telehealth In General Practice, Australia The Royal Australian College of General Practitioners (RACGP) recognises that telehealth provides considerable opportunities to improve health outcomes for patients in outer metropolitan, regional, rural and remote communities and is committed to supporting the profession during the telehealth rollout. | 03 June 2011 |
| Breaking Through How GP-Led Consortia Can Unlock The Full Potential Of The NHS Dr Michael Dixon, chairman of the NHS Alliance, today called on the Government to speed up the process of NHS reform in areas where GP-led consortia are ready, willing and able to get on with the job of improving services for patients. | 03 June 2011 |
| NHS Alliance And NAPC In Support Of Clinically-Led Commissioning The NHS Alliance and the National Association of Primary Care have joined forces to support clinically-led commissioning. In a letter sent to Professor Steve Field, chair of the government's NHS Future Forum review, both organisations highlighted the reasons why clinically-led commissioning is the way forward for the NHS and its patients. | 03 June 2011 |
| Prostate / Prostate Cancer News | |
| Experimental Vaccine Made From Frozen Immune Cells Shows Promise For Prostate Cancer Patients Metastatic prostate cancer patients who received an investigational vaccine made from their own frozen immune cells lived 10 months longer than those not treated with it, according to data being presented by researchers from the Kimmel Cancer Center at Jefferson at the 2011 American Society of Clinical Oncology annual meeting in Chicago on Saturday, June 4. | 03 June 2011 |
| Psychology / Psychiatry News | |
| Depression And Negative Thoughts We all have our ups and downs-a fight with a friend, a divorce, the loss of a parent. But most of us get over it. Only some go on to develop major depression. Now, a new study, which will be published in an upcoming issue of Psychological Science, a journal of the Association for Psychological Science, suggests part of the reason may be that people with depression get stuck on bad thoughts because they're unable to turn their attention away. | 03 June 2011 |
| Work-Family Conflict: The Blame Game When the demands of work and family conflict, is the job blamed, is the family role blamed or is blame placed on both? And what are the consequences?A new study by Elizabeth M. Poposki, Ph.D. | 03 June 2011 |
| Children And Depression From a distance, Callie (not her real name) appears to be a normal if quiet 5-year-old girl. But when faced with a toy that blows large soap bubbles - an activity that makes the vast majority of kindergarteners squeal and leap with delight - she is uninterested in popping the bubbles or taking a turn with the gun herself. | 03 June 2011 |
| Using Mind And Body To Solve A Problem When we've got a problem to solve, we don't just use our brains but the rest of our bodies, too. The connection, as neurologists know, is not uni-directional. Now there's evidence from cognitive psychology of the same fact. | 03 June 2011 |
| Could The Legal Concept Of Criminal Responsibility Be Challenged By Neuroscience? Just before 10:00 a.m. on June 20, 2001, a uniformed police officer was dispatched to do what he thought was a routine welfare check at a home in Houston, Texas. When the officer met Andrea Yates at the door, she immediately told him, "I just killed my kids. | 03 June 2011 |
| Study Of Gambling Behaviour May Improve Understanding Of Risky Choices And Gambling Addictions Psychology researchers at the University of Alberta have found an interesting wrinkle in the decision- making process people use when gambling: People confronted with risky choices respond differently when they rely on past experiences, rather than when they just focus on the odds of winning or losing. | 03 June 2011 |
| The Color Red Makes Us React Faster And More Forcefully What links speed, power, and the color red? Hint: it's not a sports car.It's your muscles.A new study, published in the latest issue of the journal Emotion, finds that when humans see red, their reactions become both faster and more forceful. | 03 June 2011 |
| Head Injuries Can Lead To An Increase In Violent Behavior Young people who have sustained a head injury during their lifetime are more likely to engage in violent behavior, according to an eight-year study from the University of Michigan School of Public Health. | 03 June 2011 |
| Mylan Receives Approval For Generic Version Of Effexor XR® Capsules Mylan Inc. (Nasdaq: MYL) announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Venlafaxine Hydrochloride (HCl) Extended-release (ER) Capsules, 37. | 03 June 2011 |
| Take That! Bullies Get Less Sleep Than Those They Pick On So it seems that being harsh toward others can actually be bad for the bully themselves. Bullying and school disciplinary problems were all associated with higher scores on a measure of sleep related breathing disorders in children according to a new study reported on this week. | 03 June 2011 |
| Public Health News | |
| As E Coli Outbreak In Germany Continues, Experts Are Concerned About Pressure On Health Facilities, Antibiotic Resistance And Preparedness Across EU As the current virulent Shiga toxin-producing Escherichia coli (STEC) outbreak in Germany spreads, experts from The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) are concerned not only about the pressure health facilities are being put under, but also the use of antibiotics and broader implications for preparedness across Europe to cope, both now and in the future. | 03 June 2011 |
| Expedition To Measure Radioactive Contaminants In Pacific The Woods Hole Oceanographic Institution (WHOI) will lead the first international, multidisciplinary assessment of the levels and dispersion of radioactive substances in the Pacific Ocean off the Fukushima nuclear power plant - a research effort funded by the Gordon and Betty Moore Foundation. | 03 June 2011 |
| Hospitalized Patients With New Type Of MRSA, Probably Of Animal Origin A distinctly new type of methicillin resistant Staphylococcus aureus (MRSA) that is not detected by traditional genetic screening methods has been discovered in patients in Irish hospitals according to research to be published in the journal Antimicrobial Agents and Chemotherapy. | 03 June 2011 |
| Copper Proves Effective Against New E. coli Strains As the World Health Organisation suggests the E. coli outbreak in Germany is a strain never before seen in an outbreak - O104:H4 - laboratory science conducted at the University of Southampton indicates a role for copper in preventing the spread of such infections. | 03 June 2011 |
| Life Line Screening Reveals Private Health Screening Survey Life Line Screening has published the results of its private health screening survey.Private health screening is becoming increasingly popular in the UK & Ireland. Whilst there are metrics on the benefits of screenings in detecting potentially life-threatening conditions early, and thereby preventing conditions such as Stroke and cardiovascular disease, Life Line Screening's report aims to provide more evidence relating to the effects of screenings on modifying behavioural change. | 03 June 2011 |
| Global 'Hotspots' Of Climate-Induced Food Insecurity Mapped A new study has matched future climate change "hotspots" with regions already suffering chronic food problems to identify highly-vulnerable populations, chiefly in Africa and South Asia, but potentially in China and Latin America as well, where in fewer than 40 years, the prospect of shorter, hotter or drier growing seasons could imperil hundreds of millions of already-impoverished people. | 03 June 2011 |
| 1 In 9 Hospital Stays Are Readmissions In 30 Days Or Less In 2008 nearly 12 percent of hospital stays were readmissions within 30 days of a previous stay, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.The federal agency's analysis, which was based on data from 15 states, also found that 7 percent of hospital stays were readmissions within 14 days of their previous stay and 4 percent were readmissions within one week. | 03 June 2011 |
| Take That! Bullies Get Less Sleep Than Those They Pick On So it seems that being harsh toward others can actually be bad for the bully themselves. Bullying and school disciplinary problems were all associated with higher scores on a measure of sleep related breathing disorders in children according to a new study reported on this week. | 03 June 2011 |
| Radiology / Nuclear Medicine News | |
| Care Act Builds On Manufacturing Industry Efforts To Ensure Safe And Effective Medical Imaging Services The Medical Imaging & Technology Alliance (MITA) voiced its support today for the "Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2011," introduced yesterday by Representatives Ed Whitfield (R-KY) and John Barrow (D-GA). | 03 June 2011 |
| Emerging Trends In Radiation Therapy For Women Over 70 With Early Stage Breast Cancer Patterns of radiation usage in breast conserving therapy for women 70 years and older with stage I breast cancer are changing: more women are opting for radioactive implants and those with estrogen positive tumors are opting out of radiation therapy, according to an abstract being presented at the American Society of Clinical Oncology annual meeting in Chicago by Thomas Jefferson University Hospital researchers on Saturday, June 4. | 03 June 2011 |
| At SIIM 2011 Siemens Showcases Imaging IT Solutions For Driving Greater Value In Radiology And Other Specialties Siemens Healthcare will showcase its portfolio of imaging information technology (IT) and workflow management solutions at the Society for Imaging Informatics in Medicine (SIIM) 2011 Annual Meeting from June 2-5, 2011, (booth 825) in the Gaylord National Resort and Convention Center, Washington, D. | 03 June 2011 |
| FDA: Breast Thermography Not A Substitute For Mammography The U.S. Food and Drug Administration today warned women not to substitute breast thermography for mammography to screen for breast cancer.Unlike mammography, in which an X-ray of the breast is taken, thermography produces an infrared image that shows the patterns of heat and blood flow on or near the surface of the body. | 03 June 2011 |
| Regulatory Affairs / Drug Approvals News | |
| FDA Seizes Elderberry Juice Concentrate At Kansas Company At the request of the U.S. Food and Drug Administration, U.S Marshals seized elderberry juice products that have been distributed by Wyldewood Cellars Inc., based in Peck, Kan., because the products are unapproved and misbranded drugs. | 03 June 2011 |
| Animas(R) Vibe™, The First Integrated Offering From Animas Corporation And Dexcom, Inc., Receives European CE Mark Approval Animas Corporation announced today the receipt of CE Mark approval for Animas® Vibe™, the first and only continuous glucose monitoring (CGM)-enabled insulin pump system with Dexcom G4™ CGM technology. | 03 June 2011 |
| FDA: Treatment With Angiotensin Receptor Blockers For High Blood Pressure Does Not Increase Risk Of Cancer The U.S. Food and Drug Administration today announced that a group of medications used to control high blood pressure, called angiotensin receptor blockers (ARBs), do not increase the risk of developing cancer in patients using the medications. | 03 June 2011 |
| ORTHOCON®, Inc. Receives 510(k) Clearance To Market HEMASORB Apply™ ORTHOCON®, Inc., a privately-held therapeutic device company, announced that the Food and Drug Administration cleared HEMASORB Apply™ for clinical use and sale in the United States. | 03 June 2011 |
| ThermoGenesis Announces 510(k) Approval For Use Of Res-Q In Preparation Of Platelet Rich Plasma ThermoGenesis Corp. (NASDAQ: KOOL), a leading supplier of innovative products and services that process and store adult stem cells, said it has received FDA clearance of its 510(k) submission for the use of its Res-Q™ 60 (Res-Q) System technology to be used for the safe and rapid preparation of autologous platelet rich plasma (PRP) from a small sample of blood at the patient's point-of-care. | 03 June 2011 |
| Stem Cells May Prevent Need For Joint Replacements, If FDA Allows It Patients' own adult stem cells show great potential in regenerative medicine, including orthopedic applications. Stem cells isolated from bone marrow can enable bone and cartilage to heal.Once removed, the patients' cells are processed and allowed to multiply in tissue culture. | 03 June 2011 |
| Rehabilitation / Physical Therapy News | |
| Workers' Compensation Update: Chiropractic Care More Valuable And Cost-Efficient For Low Back Pain Vs. Physician Care, Physical Therapy A recent study conducted by medical and healthcare professionals outside the chiropractic profession, "Health Maintenance Care in Work-Related Low Back Pain and Its Association with Disability Recurrence," (Journal of Occupational and Environmental Medicine, April 2011, Vol. | 03 June 2011 |
| Sexual Health / STDs News | |
| 25% Drop In New HIV Infections Between 2001 And 2009 Worldwide Between 2001 and 2009 the number of new HIV infections per year dropped almost 25%, according to UNAIDS, the Joint United Nations Program on HIV/AIDS. During this period India's annual rate went down by over 50%, and 35% in South Africa. | 03 June 2011 |
| Study Examines Sexual Communication In Transgender Community A new study from North Carolina State University shows that talking about safer sex is a complicated process for individuals in the transgender community. The finding may help efforts to promote safer sex practices in a community facing high HIV rates - and also sheds light on broader questions related to safer sex for everyone. | 03 June 2011 |
| Sleep / Sleep Disorders / Insomnia News | |
| Take That! Bullies Get Less Sleep Than Those They Pick On So it seems that being harsh toward others can actually be bad for the bully themselves. Bullying and school disciplinary problems were all associated with higher scores on a measure of sleep related breathing disorders in children according to a new study reported on this week. | 03 June 2011 |
| Smoking / Quit Smoking News | |
| American Lung Association Encourages LGBT Community Members To Take Pride In Their Health Throughout June, the American Lung Association is encouraging members of the lesbian, gay, bisexual and transgender (LGBT) community to honor national LGBT Pride Month by focusing on their health-particularly by quitting smoking or encouraging their friends to do so. | 03 June 2011 |
| Sports Medicine / Fitness News | |
| Hip Strengthening Exercises Improved Running Mechanics, Lessened Knee Pain Hip strengthening exercises performed by female runners not only significantly reduced patellofemoral pain - a common knee pain experienced by runners - but they also improved the runners' gaits, according to Indiana University motion analysis expert Tracy Dierks. | 03 June 2011 |
| Exercise Should Be Considered For PTSD Therapy Doctors are increasingly prescribing exercise as medicine for their patients to prevent and treat disease and injury. A growing collection of evidence also suggests that exercise can be therapeutic for individuals suffering from Posttraumatic Stress Disorder (PTSD), including victims of rape. | 03 June 2011 |
| Study Compares Health Benefits Of Yoga And Exercise While numerous studies have shown short-term physical and psychological benefits from yoga, research being presented today at the 58th Annual Meeting of the American College of Sports Medicine and 2nd World Congress on Exercise is Medicine® looks at how long-time practitioners of yoga compare to habitual exercisers. | 03 June 2011 |
| New Studies Reinforce Benefits Of Drinking Lowfat Chocolate Milk After A Tough Workout New research suggests an effective recovery drink may already be in your refrigerator: lowfat chocolate milk. Grabbing lowfat chocolate milk after a tough workout helped give both trained and amateur athletes a post-exercise training advantage, according to three new studies presented at the American College of Sports Medicine and published in the Journal of Strength and Conditioning Research this month. | 03 June 2011 |
| Two Minutes Of Exercise A Day Can Keep The Pain Away As little as two minutes of exercise a day can reduce pain and tenderness in adults with neck and shoulder problems, according to research being presented today at the 58th Annual Meeting of the American College of Sports Medicine and 2nd World Congress on Exercise is Medicine®. | 03 June 2011 |
| Sports Participation, Fitness Linked To Academic Achievement Preteens in Portugal with higher levels of fitness and sports participation performed better in the classroom, according to research being presented today at the American College of Sports Medicine's 58th Annual Meeting and 2nd World Congress on Exercise is Medicine®. | 03 June 2011 |
| Moving Backward Helps Injured Knees Move Ahead Those recovering from knee injuries might do well to heed research being presented today at the American College of Sports Medicine's 58th Annual Meeting and 2nd World Congress on Exercise is Medicine®. | 03 June 2011 |
| Stem Cell Research News | |
| One Step Closer To A Stem Cell Treatment To Prevent Leukemia Returning Researchers at King's College London have identified a way of eliminating leukaemic stem cells, which could lead to new treatments that may enable complete remission for leukaemia patients. An early study in mice has shown that leukaemic stem cells can be abolished by suppressing two proteins found in the body. | 03 June 2011 |
| ThermoGenesis Announces 510(k) Approval For Use Of Res-Q In Preparation Of Platelet Rich Plasma ThermoGenesis Corp. (NASDAQ: KOOL), a leading supplier of innovative products and services that process and store adult stem cells, said it has received FDA clearance of its 510(k) submission for the use of its Res-Q™ 60 (Res-Q) System technology to be used for the safe and rapid preparation of autologous platelet rich plasma (PRP) from a small sample of blood at the patient's point-of-care. | 03 June 2011 |
| Stem Cells May Prevent Need For Joint Replacements, If FDA Allows It Patients' own adult stem cells show great potential in regenerative medicine, including orthopedic applications. Stem cells isolated from bone marrow can enable bone and cartilage to heal.Once removed, the patients' cells are processed and allowed to multiply in tissue culture. | 03 June 2011 |
| Case Western Reserve And Edheads Advance Science Education By Using Clinical Trials, Launch Online Education Tools About Stem Cells The National Center for Regenerative Medicine (NCRM) at Case Western Reserve University School of Medicine is teaming up with Edheads, a provider of online education tools, to launch web-based education modules about stem cells. | 03 June 2011 |
| Stroke News | |
| Use Of Clot Busters For Stroke Increased From 2005 To 2009, But Still Low The use of clot-busting drugs to treat acute ischemic stroke increased from 2005 through 2009 - but is still low, according to research reported in Stroke: Journal of the American Heart Association. | 03 June 2011 |
| Swine Flu News | |
| Fraunhofer USA CMB Announces Positive Phase 1 Interim Results For Its Plant-Produced H1N1 Influenza Vaccine Fraunhofer USA Center for Molecular Biotechnology (CMB), a not-for-profit, Delaware-based organization focused on developing a proprietary plant-based protein production platform and its applications in vaccine and therapeutic fields, today announced positive interim results from the first human trial of plant-produced H1N1 influenza vaccine (HAC1) that began on September 13, 2010. | 03 June 2011 |
| IBio Announces Positive H1N1 Influenza Vaccine Clinical Trial Results iBio, Inc. (NYSE AMEX: IBIO) today announced positive interim results from a Phase 1 clinical trial of an iBioLaunch™ platform-produced subunit vaccine directed against Influenza A/California/04/09 (H1N1). | 03 June 2011 |
| Transplants / Organ Donations News | |
| Infant With Rare Disorder Urgently Needs Lung Transplant To Survive Katelyn Julana Policastro was born April 27th, 2011 at St. John's Hospital in Oxnard, California. The first day of her life was filled with joy and she seemed like a healthy little baby girl. | 03 June 2011 |
| Tropical Diseases News | |
| Cholera Vaccination Strategies For Zimbabwe Suggested By UF Researchers Mathematical models analyzing how a cholera outbreak spread in Zimbabwe are providing new insights into the most effective vaccination strategies for preventing future cholera epidemics, according to University of Florida researchers. | 03 June 2011 |
| Urology / Nephrology News | |
| Physicians Discover How Cancer Drug Works To Help Prevent Recurrent Kidney Disease A collaboration of Miller School physicians, surgeons and scientists has unlocked the mechanism of a drug used to prevent recurrent kidney disease. The finding, which has implications for the diagnosis and treatment of many other diseases, involves the action of rituximab, a B-cell lymphoma therapy, in treating recurrent focal segmental glomerulosclerosis (FSGS) in children and young adults. | 03 June 2011 |
| New Strategy To Combat Cystitis One in three women will be faced at least once in her life with cystitis, for some the start of a constantly recurring infection. Cystitis is caused by Escherichia coli bacteria which fasten on to the wall of the bladder by means of thread-like structures (pili). | 03 June 2011 |
| Vascular News | |
| New Device Offers Revolutionary Treatment For Difficult-to-Treat Brain Aneurysms Physicians at Rush University Medical Center are offering a new and effective treatment to patients suffering from complex brain aneurysms. The recently FDA-approved technology called the Pipeline Embolization Device (PED gives doctors the ability for the very first time to treat some of the most complex and dangerous brain aneurysms using minimally invasive techniques. | 03 June 2011 |
| Veterinary News | |
| Keeping Pets Healthy During Hot Weather Extra care should be taken to protect pets in the current hot weather, Defra's Chief Vet Nigel Gibbens said today. In a statement issued jointly with the RSPCA and British Veterinary Association, Mr Gibbens urged the public to think about the effects of hot weather on their pets and to take the right steps to ensure their welfare. | 03 June 2011 |
| Discovery Of New MRSA Strain In Milk, UK A new strain of meticillin-resistant Staphylococcus aureus (MRSA) has been discovered by scientists at the University of Cambridge Veterinary School. The findings are published today in the journal The Lancet Infectious Diseases. | 03 June 2011 |
| Water - Air Quality / Agriculture News | |
| New MRSA Variant Detected In Cow's Milk Can Evade Some Existing Detection Methods; Study Reveals Evidence That Cows Could Be A Source Of Human MRSA An Article published Online First by The Lancet Infectious Diseases reports detection of a new variant of meticilin-resistant Staphylococcus aureus in cow's milk-genetically different to existing MRSA strains-from the UK and Denmark. | 03 June 2011 |
| Expedition To Measure Radioactive Contaminants In Pacific The Woods Hole Oceanographic Institution (WHOI) will lead the first international, multidisciplinary assessment of the levels and dispersion of radioactive substances in the Pacific Ocean off the Fukushima nuclear power plant - a research effort funded by the Gordon and Betty Moore Foundation. | 03 June 2011 |
| Beef: America's Favorite Protein Is An Essential Building Block The new visual icon released by the U.S. Department of Agriculture (USDA) and the Department of Health and Human Services (HHS), called MyPlate, offers simple and actionable steps to build healthier diets. | 03 June 2011 |
| Global 'Hotspots' Of Climate-Induced Food Insecurity Mapped A new study has matched future climate change "hotspots" with regions already suffering chronic food problems to identify highly-vulnerable populations, chiefly in Africa and South Asia, but potentially in China and Latin America as well, where in fewer than 40 years, the prospect of shorter, hotter or drier growing seasons could imperil hundreds of millions of already-impoverished people. | 03 June 2011 |
| Women's Health / Gynecology News | |
| Saudi Women Call On Sec. Hillary Clinton To Publicly Support Their Right To Drive More than 10,000 people from all 50 US states have endorsed a an open letter by a coalition of leading Saudi Arabian women's rights activists calling on Secretary of State Hillary Clinton to issue a public statement supporting their right to drive. | 03 June 2011 |
| New Adult Model Of Rett Syndrome An IRSF funded study published in the journal Science has shown that the childhood disorder Rett syndrome, can be reestablished in adult animals by "switching off" a critical disease causing gene in healthy adult animals. | 03 June 2011 |
| FDA: Breast Thermography Not A Substitute For Mammography The U.S. Food and Drug Administration today warned women not to substitute breast thermography for mammography to screen for breast cancer.Unlike mammography, in which an X-ray of the breast is taken, thermography produces an infrared image that shows the patterns of heat and blood flow on or near the surface of the body. | 03 June 2011 |
| You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y . |
Tidak ada komentar:
Posting Komentar